NOVARTIS AG - Ordinary Shares (NVS)

Historical Holders from Q1 2014 to Q4 2025

Type / Class: Equity / Ordinary Shares
Symbol: NVS on NYSE
Shares outstanding: 2,181,288,547
Price per share: $137.87
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 133,862,820
Total reported value: $17,165,003,719
% of total 13F portfolios: 0.03%
Share change: +313,429
Value change: +$50,895,815
Avg buy value change: +0%
Avg sell value change: -0%
Number of holders: 1,378

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of NOVARTIS AG - Ordinary Shares (NVS) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	6.4%		$15,174,788,163		139,602,467		UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	30 Sep 2024

As of 30 Sep 2025, NOVARTIS AG - Ordinary Shares (NVS) has 1,378 institutional shareholders filing 13F forms. They hold 133,862,820 shares. of 2,181,288,547 outstanding shares (6.1%) .

Institutional Holders of NOVARTIS AG - Ordinary Shares (NVS) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2025 Q4	668,863	$93,142,650	+$3,565,458			13,787%	67
2025 Q3	133,862,820	$17,165,003,719	+$50,895,815	$285,147,356	$198,601,947	12,824%	1,378
2025 Q2	133,423,708	$16,144,171,651	-$490,686,254	$205,384,174	$206,393,282	12,101%	1,369
2025 Q1	137,631,894	$15,349,976,244	+$873,106,714	$203,080,350	$182,184,777	11,148%	1,335
2024 Q4	130,310,278	$12,695,223,854	-$228,480,821	$151,659,018	$127,963,732	9,731%	1,322
2024 Q3	131,877,776	$15,188,426,571	-$629,783,262	$210,240,543	$128,312,996	11,502%	1,298
2024 Q2	137,608,636	$14,656,359,885	-$143,854,047	$163,567,784	$157,963,742	10,646%	1,296
2024 Q1	140,077,928	$13,559,673,499	-$126,753,089	$83,729,488	$111,432,960	9,673%	1,236
2023 Q4	343,362	$34,630,584	-$6,158,540			10,097%	15
2023 Q3	141,257,515	$14,348,547,400	-$4,451,843	$138,021,659	$138,254,578	10,186%	1,198
2023 Q2	147,654,315	$14,869,304,793	-$2,343,971,180	$160,831,953	$473,181,551	10,091%	1,176
2023 Q1	162,405,159	$14,915,434,489	-$599,352,761	$127,144,900	$268,867,400	9,200%	1,150
2022 Q4	170,564,336	$15,451,182,852	-$838,630,476	$182,084,608	$374,606,509	9,072%	1,159
2022 Q3	179,354,435	$13,636,003,965	-$1,528,242,729	$111,783,000	$194,780,019	7,600.99%	1,063
2022 Q2	199,271,200	$16,844,841,045	-$489,531,820	$99,800,000	$162,233,021	8,452.98%	1,118
2022 Q1	206,077,509	$18,084,227,374	-$258,119,859	$109,702,000	$197,196,000	8,775%	1,112
2021 Q4	210,474,179	$18,407,771,374	-$804,245,009	$112,819,000	$414,494,022	8,746.98%	1,128
2021 Q3	218,660,665	$17,883,551,762	+$334,089,003	$80,481,000	$368,929,000	8,178%	1,066
2021 Q2	216,672,469	$19,769,267,150	-$95,492,513	$43,503,000	$127,856,000	9,123.99%	1,105
2021 Q1	218,010,382	$18,638,880,538	-$804,920,670	$66,627,788	$139,525,252	8,548%	1,125
2020 Q4	227,741,786	$21,504,306,141	+$235,971,480	$101,203,386	$215,979,548	9,442.94%	1,163
2020 Q3	226,040,278	$19,651,573,098	-$999,899,035	$108,241,381	$168,060,790	8,695.99%	1,103
2020 Q2	237,474,080	$20,732,560,418	-$812,720,660	$93,295,570	$168,470,000	8,733.93%	1,116
2020 Q1	245,916,791	$20,280,828,097	-$536,420,196	$89,403,003	$137,656,001	8,244.93%	1,116
2019 Q4	257,394,315	$24,370,448,069	+$1,317,592,045	$118,860,000	$167,130,000	9,468.94%	1,155
2019 Q3	231,632,072	$20,130,654,770	-$998,361,615	$132,695,000	$142,970,000	8,689.99%	1,076
2019 Q2	254,663,810	$23,240,806,593	-$1,283,175,522	$103,568,000	$215,279,000	9,130.94%	1,079
2019 Q1	264,856,832	$25,389,058,027	-$71,800,246	$87,723,000	$143,950,000	9,613.9%	1,115
2018 Q4	272,632,850	$23,393,072,414	+$1,013,449,870	$70,878,005	$103,649,008	8,580.99%	1,074
2018 Q3	259,352,378	$22,343,282,028	+$463,977,493	$58,234,000	$82,970,000	8,616%	1,007
2018 Q2	253,820,335	$19,172,148,163	+$310,843,199	$25,842,000	$91,586,000	7,554%	972
2018 Q1	255,816,097	$20,677,598,455	+$329,133,983	$44,132,000	$80,230,000	8,085%	1,000
2017 Q4	250,432,225	$21,026,372,222	-$565,407,489	$41,736,000	$57,881,003	8,396%	992
2017 Q3	257,752,250	$22,123,350,633	-$115,911,737	$25,275,000	$41,346,000	8,584.99%	926
2017 Q2	259,279,569	$21,635,711,063	-$435,593,217	$42,053,000	$65,061,000	8,346.98%	908
2017 Q1	253,285,897	$18,794,905,164	+$1,101,978,065	$65,291,007	$27,790,000	7,426.99%	897
2016 Q4	237,145,163	$17,239,408,619	+$771,767,681	$76,409,011	$94,057,000	7,283.98%	893
2016 Q3	224,715,395	$17,742,572,223	-$13,960,208	$41,944,000	$40,003,000	7,895.99%	863
2016 Q2	222,683,733	$18,375,079,880	-$252,756,535	$49,568,000	$43,008,000	8,250.97%	867
2016 Q1	222,467,716	$16,143,630,534	+$157,412,579	$21,400,000	$28,809,000	7,244%	859
2015 Q4	232,789,610	$20,027,482,108	+$58,075,260	$41,168,000	$26,051,000	8,603.98%	921
2015 Q3	233,551,675	$21,465,082,753	+$272,156,508	$53,066,000	$40,460,000	9,191.96%	915
2015 Q2	231,313,869	$22,749,332,109	+$105,239,133	$17,975,000	$55,491,000	9,834%	935
2015 Q1	233,703,655	$23,050,151,780	-$41,935,547	$15,459,000	$30,507,000	9,861.01%	929
2014 Q4	234,178,546	$21,698,585,347	+$109,315,028	$66,938,000	$159,471,000	9,265.99%	901
2014 Q3	230,196,961	$21,667,518,722	-$347,321,799	$104,195,000	$176,506,000	9,412.97%	862
2014 Q2	235,598,177	$21,327,581,573	-$159,409,008	$103,170,000	$157,480,000	9,052.96%	835
2014 Q1	237,211,976	$20,165,513,062	-$334,984,789	$188,015,000	$166,082,000	8,501.97%	824